Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. (GLUE) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 66 transactions totaling $287.6M, demonstrating a bullish sentiment with $265.9M in net insider flow. The most recent transaction on Sep 20, 2024 involved a sale of 1,132,566 shares valued at $7.4M.
GLUE Insider Activity Summary
Who Is Buying GLUE Stock?
No significant insider buying has been recorded for GLUE in the recent period.
Who Is Selling GLUE Stock?
No significant insider selling has been recorded for GLUE in the recent period.
Is Monte Rosa Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GLUE is bullish with an Insider Alignment Score of 96/100 and a net flow of $265.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
GLUE Frequently Asked Questions
Understanding GLUE Insider Activity
Insider trading at Monte Rosa Therapeutics, Inc. (GLUE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading GLUE stock, having executed 66 transactions in the past 90 days. The most active insider is Partners 17, L.p. Nea (Executive), who has made 4 transactions totaling $19.9M.
Related Tools
Track Monte Rosa Therapeutics, Inc. Insider Activity
Get notified when executives and directors at GLUE file new Form 4 transactions